No insider purchase over the last 90 days. The latest was filed 12 Feb 2026.
discoverIE Group plc is a listed company. Its insiders report their share dealings to RNS (LSE). Between 18 October 2025 and 18 October 2026, 3 insiders published 3 filings.
No insider sold shares on the market over the period. Instead, the filings list 3 purchases totalling €123k, made by 3 insiders. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. One trade stands out by size: a purchase of €103k from Bruce Thompson, disclosed on 11 December 2025. On the buying side, the filings list 2 board members and 1 senior executive among the declarants.
Within a 30-day window, 1 purchase overlapped with buying by a second insider. Purchases made close together by different insiders form what is called a cluster. The most recent open-market purchase was published on 12 February 2026, 247 days ago. Filings reach the RNS (LSE) feed a median of 1 day after the trade. The legal deadline for notifying a trade is three business days (UK MAR).
Across the 834 companies tracked on its exchange, the median is 6 filings; at 3 filings, this issuer sits below that mark. The full history, which starts in 2023, counts 18 purchases against no sales.
This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
20 of 20 declarations
discoverIE Group plc is a UK-based company specializing in the design and manufacture of customized electronic solutions. It primarily operates in the automotive, energy, and industrial sectors.